Skip to content

Develops bio-based, biodegradable PHBV polymers as alternatives to conventional plastic materials.

Introduce me to Biotic
Biotic website sharing image

Image source: company website sharing image

Founders & company facts

Sources reviewed:

Reported cumulative funding

$4,750,000 · Source

This index includes companies with publicly reported total funding up to US$150 million. This is a reported total, not valuation, the latest round size or confirmation of an open round. Funding reviewed: .

Documented founding team

Founded
2020Source
Reported Israeli location
NetanyaSource
Team range in directory
11-50Source
Reported business model
B2BSource

Selected disclosed financing

Selected transactions, with dates, funding types and reported participants.

  1. Jan 2024$1.5MSeed
    Named participants

    No confirmed names included here

    Source
  2. Jan 2024$1MNon-equity funding
    Named participants

    No confirmed names included here

    Source

Company overview

Product & customers

Biotic develops bio-based PHBV polymers from the PHA family as alternatives to conventional plastics. Its process uses biological feedstocks, including marine biomass, and the company describes materials whose properties can be adapted for different manufacturing applications.

Commercial potential · editorial analysis

The opportunity is to enter existing material supply chains with a product that meets practical processing requirements. Demand could come from packaging and manufactured goods, provided performance and delivered cost are competitive for a specific application.

What to validate

Review independent material testing, degradation conditions, lifecycle evidence and production yields. Feedstock availability, customer qualification cycles and the capital needed for manufacturing scale are crucial; laboratory properties alone do not establish a commercially viable substitute.

Product source reviewed on . Company source